[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)
date : 10/28/2024
Tags: Cardiovascular Diseases, NCDs
In 2019, Japan enacted the “Basic Act on Countermeasures for Stroke, Heart Disease and Other CVDs to Extend Healthy Life Expectancies”, leading to comprehensive nationwide efforts to promote CVD control. Based on this law, the Japanese Government established the National Plan for the Promotion of Measures Against Cerebrovascular and Cardiovascular Diseases (hereinafter “National Plan”), while prefectures created their own Prefectural Plans for CVD control (hereinafter “Prefectural Plans”). These plans are subject to periodic review, with the National Plan revised in April 2023 and the Prefectural Plans collectively updated in April 2024, marking the beginning of their second phase. During the first phase of the National Plan, the COVID-19 pandemic presented challenges, but significant progress was made in areas like the Model Projects for Integrated Centers for Stroke and Heart Disease Support (hereinafter “Integrated Support Centers”) and the development of a CVD Database, including substantial discussions on these initiatives. However, there remain challenges in ensuring these measures adequately reflect the needs of actual service users – patients and affected individuals.
Currently, 30 prefectures have established Integrated Support Centers, serving as key hubs for regional CVD control efforts. Additionally, CVD measures are often focused on acute care, with insufficient resources dedicated to chronic care and prevention efforts, as has been noted by various stakeholders. Particular emphasis needs to be placed on promoting regional clinical pathways, cardiac rehabilitation, and education to prevent recurrence. Addressing these issues and enhancing the effectiveness of CVD control measures, while developing more beneficial systems, requires building policies that are responsive to the needs of people living with CVDs.
This symposium aims to foster collaboration among industry, government, academia, and civil society to promote CVD control based on the perspectives of people living with CVDs, advancing the implementation of effective measures in the Second Phase CVD Control Plans.
[Event Overview]
- Date & Time: Friday, November 22, 2024; 15:00-17:00 JST
- Format:Hybrid (In-Person and Online (Zoom Webinars))
- Venue: Global Business Hub Tokyo (Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo) >>Access
- Language: Japanese
- Participation Fee: Free
- Organizer: Health and Global Policy Institute (HGPI)
- Support: Japanese Circulation Association
- Capacity: Venue 80/ Online 500
[Program] (Titles omitted, no particular order)
15:00-15:05 | Opening Remarks |
Hanako Jimi (Member, House of Councillors; Executive Director, Parliamentary Association for Follow-up on Stroke and Cardiovascular Disease Control Measures) | |
15:05-15:10 | Explanatory Introduction |
Ryoji Noritake (Chair, HGPI) | |
15:10-15:30 | Keynote Lecture 1 “Japan’s Progress on CVD Control in and Expectations for the Roles of People Living With or Affected by CVDs” |
Shinya Tsuruta (Director, Cancer and Disease Control Division, Public Health Bureau, Ministry of Health, Labour and Welfare (MHLW)) | |
15:30-15:50 | Keynote Lecture 2 “Necessary Steps for Promoting CVD Control Through Unified Collaboration Among Industry, Government, Academia, and Civil Society” |
Issei Komuro (Professor, Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo) | |
16:00-16:50 | Plenary Roundtable Discussion “Next Steps in Achieving Citizen-Centered CVD Policies” |
Panelists: |
|
16:50-17:00 | Discussion and Concluding Remarks |
Kiyoshi Kurokawa (Honorary Chairman for Life, HGPI) |
Top Research & Recommendations Posts
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [New Report] Policy Priorities for Super-Ageing Japan: Health Innovation and Economic Growth in the COVID-19 Pandemic Era (February 24, 2021)
- [Report and Recommendations] Discussion Points in Healthcare DX Project Expert Panel Meeting (April 2, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2024-09-26
[Registration Closed] HGPI Salon Special Edition “The 2024 U.S. Presidential Election’s Impact on Japan’s Healthcare Policies: Future Implications for U.S.-China Relations and U.S.-Japan Cooperation” (October 28, 2024)
-
2024-10-07
[Registration Open] Planetary Health Expert Meeting “Building the Future of Healthcare: A Vision for Sustainable and Resilient Health Systems with GGHH” (November 5, 2024)
-
2024-10-09
[Registration Open] (Webinar) The 128th HGPI Seminar “Viewing Healthcare Disparities Through the Lens of Breast Cancer Treatment” (October 29, 2024)
-
2024-10-24
[Event Report] HGPI Salon Special Edition “Overcoming Infectious Diseases through Partnership: Focusing on examples of promoting technology transfer of antimicrobial agents” (October 21, 2024)
-
2024-10-28
[Registration Open] (Hybrid Format) Public Symposium “Promoting CVD Control Based on the Needs of People Living with or Affected by Cardiovascular Diseases: Towards Effective Implementation of the Second Phase CVD Control Plans” (November 22, 2024)